BSECompany Update4d ago · 21 Oct 2026, 11:32 am

Intimation regarding receipt of ANVISA Inspection Report

Smruthi Organics Ltd · 540686

✦ AI SummaryRegulatory

Smruthi Organics Ltd has received an inspection report from the Brazilian Health Regulatory Agency (ANVISA) for its Unit II, which has been classified as 'Complies with Good Manufacturing Practices with Corrective Action'. The report indicates conditions for certification in respect of the inspected active pharmaceutical ingredient. The company will make further disclosures upon receipt of the final GMP certificate.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Smruthi Organics Ltd - 540686 - Intimation Regarding Receipt Of ANVISA Inspection Report

Attachments (1)

📄

e5f8684f-00a7-46f8-bdf8-fa016a9d63cd.pdf

pdf

Download →
View document text
Smruthi Organics Limited Date: 21 October, 2026 To To Corporate Relation Department Listing Department BSE Limited Metropolitan Stock Exchange of India Ltd P. J. Tower, Dalal Street, Building A, Unit 205A, 2nd Floor, Mumbai—-400001. Piramal Agastya Corporate Park, L.B.S Road, Kurla West, Mumbai - 400070 Symbol: SMRUTHIORG Scrip Code: 540686 Subject: Intimation regarding receipt of ANVISA Inspection Report- UnitIl Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has received the inspection report issued by the Brazilian Health Regulatory Agency (ANVISA) in respect of its Unit Il situated at Chincholi, Solapur, Maharashtra, following an inspection conducted from 7 June 2026 to 11 June 2026. As per the report, the inspected establishment has been classified as “Complies with Good Manufacturing Practices with Corrective Action.” The report also indicates that the establishment has conditions for certification in respect of the inspected active pharmaceutical ingredient. The receipt of the inspection report represents an important development inthe process of obtaining the relevant GMP certificate. The final GMP certificate has not yet been received by the Company as of the date of this intimation. The Companwiyll make further disclosures, as applicable, upon receipt of the certificate. This is for your information and records. Thanking You, For Smruthi Organics Limited Companv Secretary & Compliance Officer OFFICE : 'BALAJI BHAVAN' 165-A, RAILWAY LINES, SOLAPUR-413 001. (INDIA) W PHONE : 2310267, 2310367, 2311467 FAXNO.: 091 - 217 - 2310268 ® MUMBAI OFFICE : PH. : 24129211 TELEFAX NO. : 097- 022 - 24155452 FACTORY : UNITII : PLOT NO. A-27, M.L.D.C. GHINCHOLI, TAL. MONOL, DIST. SOLAPUR - 413 255. (INDIA) PHONE : 2357491 to 2357494 & FAX: 0217-235749% & VISIT US : www smruthiorganics.com E-mail : eaga@smiruthiorganics.com